Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:854507.
doi: 10.1155/2015/854507. Epub 2015 Nov 10.

Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers

I V Lyadova  1 , A V Panteleev  1
Affiliations
Review

Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers

I V Lyadova et al. Mediators Inflamm. 2015.

Abstract

The outcome of Mycobacterium tuberculosis (Mtb) infection ranges from a complete pathogen clearance through asymptomatic latent infection (LTBI) to active tuberculosis (TB) disease. It is now understood that LTBI and active TB represent a continuous spectrum of states with different degrees of pathogen "activity," host pathology, and immune reactivity. Therefore, it is important to differentiate LTBI and active TB and identify active TB stages. CD4(+) T cells play critical role during Mtb infection by mediating protection, contributing to inflammation, and regulating immune response. Th1 and Th17 cells are the main effector CD4(+) T cells during TB. Th1 cells have been shown to contribute to TB protection by secreting IFN-γ and activating antimycobacterial action in macrophages. Th17 induce neutrophilic inflammation, mediate tissue damage, and thus have been implicated in TB pathology. In recent years new findings have accumulated that alter our view on the role of Th1 and Th17 cells during Mtb infection. This review discusses these new results and how they can be implemented for TB diagnosis and monitoring.

PubMed Disclaimer

References

    1. Barry C. E., Jr., Boshoff H. I., Dartois V., et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nature Reviews Microbiology. 2009;7(12):845–855. doi: 10.1038/nrmicro2236. - DOI - PMC - PubMed
    1. Schluger N. W., Rom W. N. The host immune response to tuberculosis. American Journal of Respiratory and Critical Care Medicine. 1998;157(3, part 1):679–691. doi: 10.1164/ajrccm.157.3.9708002. - DOI - PubMed
    1. Flynn J. L., Chan J. Immunology of tuberculosis. Annual Review of Immunology. 2001;19:93–129. doi: 10.1146/annurev.immunol.19.1.93. - DOI - PubMed
    1. Boom W. H., Canaday D. H., Fulton S. A., Gehring A. J., Rojas R. E., Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis. 2003;83(1–3):98–106. doi: 10.1016/s1472-9792(02)00054-9. - DOI - PubMed
    1. North R. J., Jung Y.-J. Immunity to tuberculosis. Annual Review of Immunology. 2004;22:599–623. doi: 10.1146/annurev.immunol.22.012703.104635. - DOI - PubMed

Publication types